Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.01 +0.11 (+0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Eloxx Pharmaceuticals (ELOX) Convertible Debt (2009 - 2010)

Updated

Analysis

Eloxx Pharmaceuticals (ELOX) Convertible Debt (2009 - 2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Eloxx Pharmaceuticals 87.58 Mn 13.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2010 82,047.00
Dec 31, 2009 52,633.00
Sep 30, 2009 18,179.00
Jun 30, 2009 6,217.00
Mar 31, 2009 1,926.00
API Access

Eloxx Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ELOX&period=max&api_key=YOUR_API_KEY